Urinary tetranor-PGDM concentrations in aspirin-intolerant asthma and anaphylaxis

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 2, 2012, Pages

  Higashi, Noritaka ^a   Mita, Haruhisa ^a   Yamaguchi, Hiromichi ^a   Fukutomi, Yuma ^a   Akiyama, Kazuo ^a   Taniguchi, Masami ^a  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,15 DIOXO 9ALPHA HYDROXY 2,3,4,5 TETRANORPROSTAN 1,20 DIOIC ACID; 11 EPIPROSTAGLANDIN F2 ALPHA; 2,3 DINOR 9ALPHA,11BETA PROSTAGLANDIN F2; CREATININE; ICOSANOID; IMMUNOGLOBULIN E; LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN; PROSTAGLANDIN D2; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ASPIRIN EXACERBATED RESPIRATORY DISEASE; CELL ACTIVATION; CREATININE URINE LEVEL; DISEASE EXACERBATION; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; MASS FRAGMENTOGRAPHY; MAST CELL; METABOLITE; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; URINE;

EID: 84856460001     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.09.019     Document Type: Article

References (13)

1. N. Higashi, H. Mita, E. Ono, Y. Fukutomi, H. Yamaguchi, and K. Kajiwara Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers J Allergy Clin Immunol 125 2010 1084 1091
2. J.D. Morrow, C. Guzzo, G. Lazarus, J.A. Oates, and L.J. Roberts II Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2 J Invest Dermatol 104 1995 937 940
3. E. Ono, M. Taniguchi, H. Mita, Y. Fukutomi, N. Higashi, and E. Miyazaki Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis Clin Exp Allergy 39 2009 72 80
4. P. Gyllfors, G. Bochenek, J. Overholt, D. Drupka, M. Kumlin, and J. Sheller Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib J Allergy Clin Immunol 111 2003 1116 1121
5. G. Bochenek, K. Nagraba, E. Nizankowska, and A. Szczeklik A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge J Allergy Clin Immunol 111 2003 743 749
6. H. Mita, S. Endoh, M. Kudoh, Y. Kawagishi, M. Kobayashi, and M. Taniguchi Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma Allergy 56 2001 1061 1067
7. W.L. Song, M. Wang, E. Ricciotti, S. Fries, Y. Yu, and T. Grosser Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans J Biol Chem 283 2008 1179 1188
8. N. Higashi, M. Taniguchi, H. Mita, M. Osame, and K. Akiyama A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma Clin Exp Allergy 32 2002 1484 1490
9. K. Daham, W.L. Song, J.A. Lawson, M. Kupczyk, A. Gulich, and S.E. Dahlen Effects of celecoxib on major prostaglandins in asthma Clin Exp Allergy 41 2011 36 45
10. N. Higashi, H. Mita, E. Ono, Y. Fukutomi, H. Yamaguchi, and K. Kajiwara Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers J Allergy Clin Immunol 125 2010 1084 1091
11. H. Mita, S. Endoh, M. Kudoh, Y. Kawagishi, M. Kobayashi, and M. Taniguchi Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma Allergy 56 2001 1061 1067
12. N. Higashi, M. Taniguchi, H. Mita, M. Osame, and K. Akiyama A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma Clin Exp Allergy 32 2002 1484 1490
13. H. Mita, Y. Yui, H. Yasueda, and T. Shida Isocratic determination of arachidonic acid 5-lipoxygenase products in human neutrophils by high-performance liquid chromatography J Chromatogr 430 1988 299 308